The p53 knowledgebase: an integrated information resource for p53 research.

Abstract:

:The p53 tumor suppressor protein plays a central role in maintaining genomic integrity by occupying a nodal point in the DNA damage control pathway. Here it integrates a wide variety of signals, responding in one of several ways, that is, cell cycle arrest, senescence or programmed cell death (apoptosis). Mutations in the tumor suppressor gene tp53, which affects the key transcriptional regulatory processes in cell growth and death, occur frequently in cancer and helps explain why p53 has been called the guardian of the genome. There is a vast body of published knowledge on all aspects of p53's role in cancer. To facilitate research, it would be helpful if this information could be collected, curated and updated in a format that is easily accessible to the user community. To this end, we initiated the p53 knowledgebase project (http://p53.bii.a-star.edu.sg). The p53 knowledgebase is a user-friendly web portal incorporating visualization and analysis tools that integrates information from the published literature with other manually curated information to facilitate knowledge discovery. This includes curated information on sequence, structural, mutation, polymorphisms, protein-protein interactions, transcription factors, transcriptional targets, antibodies and post-translational modifications that involve p53. The goal is to collect and maintain all relevant data on p53 and present it in an easily accessible format that will be useful to researchers in the field.

journal_name

Oncogene

journal_title

Oncogene

authors

Lim YP,Lim TT,Chan YL,Song AC,Yeo BH,Vojtesek B,Coomber D,Rajagopal G,Lane D

doi

10.1038/sj.onc.1209952

subject

Has Abstract

pub_date

2007-03-08 00:00:00

pages

1517-21

issue

11

eissn

0950-9232

issn

1476-5594

pii

1209952

journal_volume

26

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.

    abstract::Upstream stimulating factor (USF2) is a basic helix-loop-helix leucine zipper transcription factor, which is found in most tissues. A critical role for USF2 in cellular proliferation has been proposed based on its importance in the regulation of various cyclins and P53 and its capability to antagonize c-myc. In this p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201584

    authors: Zhang ZC,Nechushtan H,Jacob-Hirsch J,Avni D,Meyuhas O,Razin E

    更新日期:1998-02-12 00:00:00

  • Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.

    abstract::The C3H/HeJ (C3H), A/J and BALB/cByJ (BALB) mouse strains are respectively resistant, sensitive and intermediate regarding the induction of lung tumors by urethane. The phenotypic difference between C3H and A/J is largely determined by the Pas1 (Pulmonary adenoma susceptibility 1) gene on chromosome 6, the A/J allele ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201357

    authors: Karasaki H,Obata M,Ogawa K,Lee GH

    更新日期:1997-10-09 00:00:00

  • Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.

    abstract::Anaplastic lymphoma kinase (ALK) was originally identified from a rare subtype of non-Hodgkin's lymphomas carrying t(2;5)(p23;q35) translocation, where ALK was constitutively activated as a result of a fusion with nucleophosmin (NPM). Aberrant ALK fusion proteins were also generated in inflammatory fibrosarcoma and a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.616

    authors: Okubo J,Takita J,Chen Y,Oki K,Nishimura R,Kato M,Sanada M,Hiwatari M,Hayashi Y,Igarashi T,Ogawa S

    更新日期:2012-11-01 00:00:00

  • CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis.

    abstract::Both chemokine receptors (CXCRs) 7 and 4 can facilitate immune cell migration and mediate a vast array of physiological and pathological events. Herein we report, in both human and animal studies, that these two CXCRs can form heterodimers in vivo and promote colorectal tumorigenesis through histone demethylation. Com...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0519-2

    authors: Song ZY,Wang F,Cui SX,Gao ZH,Qu XJ

    更新日期:2019-02-01 00:00:00

  • HSP110 promotes colorectal cancer growth through STAT3 activation.

    abstract::Heat shock protein 110 (HSP110) is induced by different stresses and, through its anti-apoptotic and chaperoning properties, helps cells survive these adverse situations. In colon cancers, HSP110 is abnormally abundant. We have recently shown that colorectal cancer patients with microsatellite instability (MSI) had an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.403

    authors: Berthenet K,Bokhari A,Lagrange A,Marcion G,Boudesco C,Causse S,De Thonel A,Svrcek M,Goloudina AR,Dumont S,Hammann A,Biard DS,Demidov ON,Seigneuric R,Duval A,Collura A,Jego G,Garrido C

    更新日期:2017-04-20 00:00:00

  • The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.

    abstract::The products of the proto-oncogenes c-jun and c-fos are known to form a complex in vivo. Complex formation appears to stabilize protein-DNA interactions and is thought to play an important functional role in transcriptional regulation. Here we show that the viral Jun oncoprotein, which differs structurally from cellul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bos TJ,Rauscher FJ 3rd,Curran T,Vogt PK

    更新日期:1989-02-01 00:00:00

  • Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.

    abstract::Intrinsic and acquired resistance to anti-EGFR antibody therapy, frequently mediated by a mutant or amplified KRAS oncogene, is a significant challenge in the treatment of colorectal cancer (CRC). However, the mechanism of KRAS-mediated therapeutic resistance is not well understood. In this study, we demonstrate that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0289-x

    authors: Knickelbein K,Tong J,Chen D,Wang YJ,Misale S,Bardelli A,Yu J,Zhang L

    更新日期:2018-08-01 00:00:00

  • Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.

    abstract::Internal tandem duplication (ITD) of the juxtamembrane (JM) domain of FLT3 is the most frequent mutation in human acute myeloid leukemia, and is significantly associated with leukocytosis and a poor prognosis. Previously we reported that FLT3 with ITD (FLT3/ITD) formed a homodimer and was autophosphorylated on tyrosin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205332

    authors: Kiyoi H,Ohno R,Ueda R,Saito H,Naoe T

    更新日期:2002-04-11 00:00:00

  • Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

    abstract::Approximately 80% of breast cancers express the estrogen receptor-alpha (ERalpha) and are treated with anti-estrogens. Resistance to these agents is a major cause of mortality. We have shown that estrogen inhibits Notch, whereas anti-estrogens or estrogen withdrawal activate Notch signaling. Combined inhibition of Not...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.323

    authors: Hao L,Rizzo P,Osipo C,Pannuti A,Wyatt D,Cheung LW,Sonenshein G,Osborne BA,Miele L

    更新日期:2010-01-14 00:00:00

  • FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

    abstract::Targeting Bruton tyrosine kinase (BTK) by ibrutinib is an effective treatment for patients with relapsed/refractory mantle cell lymphoma (MCL). However, both primary and acquired resistance to ibrutinib have developed in a significant number of these patients. A combinatory strategy targeting multiple oncogenic pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.155

    authors: Li Y,Bouchlaka MN,Wolff J,Grindle KM,Lu L,Qian S,Zhong X,Pflum N,Jobin P,Kahl BS,Eickhoff JC,Wuerzberger-Davis SM,Miyamoto S,Thomas CJ,Yang DT,Capitini CM,Rui L

    更新日期:2016-12-01 00:00:00

  • Effects of methylation on expression of TMS1/ASC in human breast cancer cells.

    abstract::Gene silencing associated with aberrant methylation of promoter region CpG islands is one mechanism in which tumor suppressor genes are inactivated in human cancers. Recently, we identified a novel gene, Target of Methylation-associated Silencing-1 (TMS1) (also called ASC), which is aberrantly methylated and silenced ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206430

    authors: Levine JJ,Stimson-Crider KM,Vertino PM

    更新日期:2003-05-29 00:00:00

  • Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin.

    abstract::Loss of PTEN tumor suppressor enhances metastatic risk in breast cancer, although the underlying mechanisms are poorly defined. We report that homozygous deletion of PTEN in mammary epithelial cells induces tubulin-based microtentacles (McTNs) that facilitate cell reattachment and homotypic aggregation. Treatment with...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.234

    authors: Vitolo MI,Boggs AE,Whipple RA,Yoon JR,Thompson K,Matrone MA,Cho EH,Balzer EM,Martin SS

    更新日期:2013-04-25 00:00:00

  • Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.

    abstract::Millions of somatic mutations have recently been discovered in cancer genomes. These mutations in cancer genomes occur due to internal and external mutagenesis forces. Decoding the mutational processes by examining their unique patterns has successfully revealed many known and novel signatures from whole exome data, b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1343-z

    authors: Pei G,Hu R,Dai Y,Zhao Z,Jia P

    更新日期:2020-07-01 00:00:00

  • Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.

    abstract::Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207557

    authors: Yatabe Y,Mitsudomi T,Takahashi T

    更新日期:2004-05-20 00:00:00

  • The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death.

    abstract::The maintenance of genome stability is essential for the cell as the integrity of genomic information guaranties reproduction of a whole organism. DNA damage occurring in response to different natural and nonnatural stimuli (errors in DNA replication, UV radiation, chemical agents, etc.) is normally detected by specia...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0980-6

    authors: Prokhorova EA,Egorshina AY,Zhivotovsky B,Kopeina GS

    更新日期:2020-01-01 00:00:00

  • UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.

    abstract::An improved understanding of the biochemical alterations that accompany tumor progression and metastasis is necessary to inform the next generation of diagnostic tools and targeted therapies. Metabolic reprogramming is known to occur during the epithelial-mesenchymal transition (EMT), a process that promotes metastasi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0885-4

    authors: Arnold JM,Gu F,Ambati CR,Rasaily U,Ramirez-Pena E,Joseph R,Manikkam M,San Martin R,Charles C,Pan Y,Chatterjee SS,Den Hollander P,Zhang W,Nagi C,Sikora AG,Rowley D,Putluri N,Zhang XH,Karanam B,Mani SA,Sreekumar A

    更新日期:2020-04-01 00:00:00

  • Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.

    abstract::Constitutive NF-kappaB activity varies widely among cancer cell lines. In this report, we studied the expression and the role of different I kappaB inhibitors in adenocarcinoma cell lines. High constitutive NF-kappaB activity and low I kappaB-alpha expression was found in a number of these cell lines. Moreover, some o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202599

    authors: Dejardin E,Deregowski V,Chapelier M,Jacobs N,Gielen J,Merville MP,Bours V

    更新日期:1999-04-22 00:00:00

  • Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.

    abstract::High CD44 expression is associated with enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the deadliest of all human carcinomas. Although alterations in autophagy and CD44 expression are associated with poor patient outcomes in various cancer types, the relationship between autophagy and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.102

    authors: Whelan KA,Chandramouleeswaran PM,Tanaka K,Natsuizaka M,Guha M,Srinivasan S,Darling DS,Kita Y,Natsugoe S,Winkler JD,Klein-Szanto AJ,Amaravadi RK,Avadhani NG,Rustgi AK,Nakagawa H

    更新日期:2017-08-24 00:00:00

  • The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.

    abstract::Topors was identified recently as a human protein that binds to topoisomerase I and p53. Topors contains a highly conserved RING domain and localizes in promyelocytic leukemia nuclear bodies. Relatively little is known regarding topors expression patterns or function. We now demonstrate that topors mRNA and protein ar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207700

    authors: Saleem A,Dutta J,Malegaonkar D,Rasheed F,Rasheed Z,Rajendra R,Marshall H,Luo M,Li H,Rubin EH

    更新日期:2004-07-08 00:00:00

  • Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.

    abstract::Procollagen lysyl hydroxylase 1 (PLOD1) is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer. Bioinformatics analysis revealed that PLOD1 is associated with the progression of GBM, particularly the most malignant mesenchymal subtype (MES). Moreover, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01635-y

    authors: Wang Z,Shi Y,Ying C,Jiang Y,Hu J

    更新日期:2021-01-08 00:00:00

  • A refined molecular taxonomy of breast cancer.

    abstract::The current histoclinical breast cancer classification is simple but imprecise. Several molecular classifications of breast cancers based on expression profiling have been proposed as alternatives. However, their reliability and clinical utility have been repeatedly questioned, notably because most of them were derive...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.301

    authors: Guedj M,Marisa L,de Reynies A,Orsetti B,Schiappa R,Bibeau F,MacGrogan G,Lerebours F,Finetti P,Longy M,Bertheau P,Bertrand F,Bonnet F,Martin AL,Feugeas JP,Bièche I,Lehmann-Che J,Lidereau R,Birnbaum D,Bertucci F,de

    更新日期:2012-03-01 00:00:00

  • The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter.

    abstract::We have previously shown that the PLAG1 gene on chromosome 8q12 is consistently rearranged in pleomorphic adenomas of the salivary glands with t(3;8)(p21;q12) translocations. The t(3;8) results in promoter swapping between the PLAG1 gene, which encodes a novel zinc finger protein, and the constitutively expressed gene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201660

    authors: Voz ML,Aström AK,Kas K,Mark J,Stenman G,Van de Ven WJ

    更新日期:1998-03-01 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth.

    abstract::Antimicrobial peptides, such as the cathelicidin LL-37/hCAP-18 and its mouse homolog cathelicidin-related antimicrobial peptide (CRAMP), are important effectors of the innate immune system with direct anti-bacterial activity. Cathelicidin is possibly involved in the regulation of tumor cell growth. The aim of this stu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.248

    authors: Li D,Beisswenger C,Herr C,Schmid RM,Gallo RL,Han G,Zakharkina T,Bals R

    更新日期:2014-05-22 00:00:00

  • Cloning and sequencing of the human c-abl 3' untranslated region.

    abstract::The human c-abl oncogene gives rise to different mRNA transcripts which vary primarily in that they possess alternative first exons. In the present study, we present the sequence for the human c-abl 3' untranslated region (3'utr) and show that while human and murine c-abl cDNA sequences are generally homologous, human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Andrews DF 3rd,Tompkins CK,Hendrickson SL,Singer JW

    更新日期:1990-03-01 00:00:00

  • Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.

    abstract::Hedgehog (Hh) is an oncogenic signaling pathway that regulates the activity of Gli transcription factors. Canonical Hh is a Smoothened- (Smo-) driven process that alters the post-translational processing of Gli2/Gli3 proteins. Though evidence supports a role for Gli action in prostate cancer (PCa) cell growth and prog...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0098-7

    authors: Li N,Truong S,Nouri M,Moore J,Al Nakouzi N,Lubik AA,Buttyan R

    更新日期:2018-04-01 00:00:00

  • Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.

    abstract::Tumor-derived DNA from a non-Hodgkin's (T cell) lymphoma patient, assayed by NIH3T3 transfection followed by inoculation of cells into nude mice, was found to contain an activated N-ras proto-oncogene. The mode of activation was determined by hybridization with N-ras-specific oligonucleotide probes detecting mutations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wodnar-Filipowicz A,Senn HP,Jiricny J,Signer E,Moroni C

    更新日期:1987-01-01 00:00:00

  • Retroviral heterogeneity in mouse lymphomas.

    abstract::Provirus modifications which can occur in tumors may lead to tumor antigenic variants. To investigate this possibility we compared the restriction fragment length patterns of mouse mammary tumor virus (MMTV), murine leukemia virus and xenotropic and mink cell-focus inducing (MCF)-related sequences, using Southern blot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Colombo MP,Ferrari G,Parmiani G,Wettstein PJ

    更新日期:1988-04-01 00:00:00

  • Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand-receptor 1 (TRAIL-R1) and tumor necrosis factor-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) are cell-surface receptors involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling. TRAIL-R1 and TRAIL-R2 gene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204103

    authors: Lee SH,Shin MS,Kim HS,Lee HK,Park WS,Kim SY,Lee JH,Han SY,Park JY,Oh RR,Kang CS,Kim KM,Jang JJ,Nam SW,Lee JY,Yoo NJ

    更新日期:2001-01-18 00:00:00

  • Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

    abstract::We studied loss of heterozygosity (LOH) in chromosome 7q in order to determine the location of a putative tumor suppressor gene (TSG) in human epithelial ovarian carcinomas. Samples were obtained from 26 primary ovarian carcinomas at the time of staging laparotomy. Paired normal and tumoral DNAs were used as templates...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zenklusen JC,Weitzel JN,Ball HG,Conti CJ

    更新日期:1995-07-20 00:00:00